<p>When <a href="https://helenkellerintl.org/our-stories/leader/sarah-bouchie/" rel="ugc noopener noreferrer" target="_blank">Sarah Bouchie</a> became CEO of <a href="https://helenkellerintl.org/" rel="ugc noopener noreferrer" target="_blank">Helen Keller International</a>, she led a listening process across the organization and sharpened how they told their story. That preparation proved critical. Within months, a third of the organization’s revenue disappeared. What followed: 300 layoffs, a refusal to close a single country office, and six months later, the Kristof Holiday Impact Prize that raised nearly $13 million. But the reason any of that matters comes down to what this organization actually does.<em> </em>For about a dollar a dose, twice a year, they can save a child’s life. That math hasn’t changed. But the funding landscape has. Here is my conversation with Sarah Bouchie, CEO of Helen Keller International.</p>